Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.7 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |